SGC-CLK-1

SGC-CLK-1, a chemical probe, is a potent and selective inhibitor of Cdc2-like kinases CLK1, CLK2, and CLK4. SGC-CLK-1 can inhibit the growth of melanoma and glioblastoma cells[1].

Product Specifications

CAS Number

[748142-15-6]

Product Name Alternative

CAF-170

UNSPSC

12352005

Target

CDK

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/sgc-clk-1.html

Concentration

10mM

Purity

99.12

Solubility

DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

FC(F)(C1=CC(NC2=NC=CC(C3=C4C=CC(OC)=NN4N=C3)=N2)=CC(OC)=C1)F

Molecular Formula

C19H15F3N6O2

Molecular Weight

416.36

References & Citations

[1]Tiek D, et, al. SGC-CLK-1: A chemical probe for the Cdc2-like kinases CLK1, CLK2, and CLK4. Curr Res Chem Biol. 2023:3:100045.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

005696 25 mg

2S-[ (1-Carboxyethyl) amino]-benzenebutanoic Acid Methyl Benzyl Ester Maleate

View Details

HY-P72808-01 20 µg

ACE2, Human (sf9, His)

View Details

HY-P72808-02 100 µg

ACE2, Human (sf9, His)

View Details

GTR15141077 1 Vial

Lentiviral human SSTR2 shRNA (UAS) - Lentiviral human SSTR2 shRNA (UAS) (25)

View Details

NBP3-24236 100 µg

Rabbit Monoclonal Cytokeratin, LMW Antibody (KRTL/7784R) - Azide and BSA Free

View Details

JH919973 1 Each

(6α,11β,16α,17α) -6,9-difluoro-11,17-dihydroxy-16-Methyl-3-oxo-Androsta-1,4-diene-17-carboxylic Acid (6α,11β,16α,17α) -6,9-difluoro-17-[[ (fluoroMethyl) thio]carbonyl]-11-hydroxy-16-Methyl-3-oxoandrosta-1,4-dien-17-yl Ester

View Details